Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.


CSE:RVV - Post by User

Revive Therapeutics Ltd.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(270)
•••
Post by sollmgon Sep 02, 2021 9:53pm
123 Views
Post# 33807881

Trading Totals - Canadian Exchanges

Trading Totals - Canadian Exchanges
House Total Jan20-Jun21 Jul21 Aug21 1Sep21 2Sep21 Totals
Industrial Alliance 1520320 -50000 1193500 0 -34500 2629320
RBC 36002348 -6495 730181 -13579 156819 36869274
TD 12076426 -24056 619151 51276 98669 12821466
Instinet -6222845 151200 335000 0 -12500 -5749145
Desjardins 1691887 -53410 363925 28980 -30000 2001382
Questrade 3040649 -616654 334580 40509 34912 2833996
CIBC 4013660 357200 326356 -21235 57393 4733374
BMO 116199 -15002 149321 2000 -140815 111703
Credential 2674859 153273 202060 0 2780 3032972
Pershing -177795 25352 108914 0 0 -43529
Leede -1075000 1445500 37000 0 0 407500
ITG 7913889 166609 36514 0 74365 8191377
Virtu -76307 -667 8209 0 0 -68765
Velocity -1649092 43569 -8812 0 -16516 -1630851
PI 3116014 4570 16900 0 9900 3147384
Ind Trading 866760 0 -18500 0 -34500 813760
Latimer -2330812 -26480 -42864 -4437 -2466 -2407059
Fidelity -1248380 0 -92320 0 0 -1340700
Canaccord -701513 130000 -122500 0 0 -694013
National 11646955 11651 -159396 -5005 -126124 11368081
Scotia 29541120 -49580 -526288 -6589 -125822 28832841
Anon -116523083 -1932879 -1411696 -96337 49383 -119914612
Raymond James 10427254 258078 -2020735 32417 4522 8701536
Merrill Lynch 1302780 35971 0 0 0 1338751
Credit Suisse 23950 -3750 0 0 0 20200
BBS 211094 -4000 0 0 0 207094
Manulife -197117 0 0 0 0 -197117
GMP -418650 0 0 0 0 -418650
Hampton 461479 0 0 0 0 461479
Interactive -216001 0 0 0 0 -216001
Mackie 137742 0 0 0 0 137742
Echelon -5055520 0 0 0 0 -5055520
Laurentian 32500 0 0 0 0 32500
Infor 6429500 0 0 0 0 6429500
Clarus -654000 0 0 0 0 -654000
Stifel Nicholas -14200 0 0 0 0 -14200
M Partners -12000 0 0 0 0 -12000
Acumen -10000 0 0 0 0 -10000
Beacon 1789000 0 0 0 0 1789000
Haywood -245033 0 -58500 -8000 0 -311533
AltaCorp 42690 0 0 0 0 42690
Integral -17000 0 0 0 0 -17000
CSE Buy-In 1189900 0 0 0 0 1189900
             
Ave SP   0.558 0.43 0.396 0.377  

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities